Less Ads, More Data, More Tools Register for FREE

Pin to quick picksItaconix Plc Regulatory News (ITX)

Share Price Information for Itaconix Plc (ITX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 176.00
Bid: 172.00
Ask: 180.00
Change: 11.00 (6.67%)
Spread: 8.00 (4.651%)
Open: 165.00
High: 179.50
Low: 165.00
Prev. Close: 165.00
ITX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

27 Jan 2014 07:00

RNS Number : 5233Y
Revolymer PLC
27 January 2014
 



27th January, 2014

Revolymer plc

Directorate Change

 

Revolymer plc ("Revolymer" or the "Company"), the British polymer technology company, announces today that its CEO, Dr Roger Pettman, will leave the Company with effect from 31 January, 2014.

Dr. Pettman has been CEO of the business since its inception in 2005 and led the flotation on the AIM Market in July 2012. He has played a significant role driving the development of a broad portfolio of polymer-based IP which is now being applied to improve the performance of a variety of consumer products within the fast moving consumer goods industry and other industrial markets.

The Company has recently used its technology to enter the nicotine gum market in Canada, and is exploring expansion of this business area to the EU and USA.

Dr Pettman's particular expertise within Revolymer has been in the establishment of the business, having identified the business model of using novel polymers to improve the performance of existing consumer products. He is now looking forward to working on establishing other new ventures. The Board thanks Dr. Pettman for his dedicated service to the Company over many years, and wishes him well in his new endeavours. The shares owned by Dr Pettman are subject to an orderly marketing agreement, which expires on 31 December 2014.

The Board is taking steps to identify a new CEO with the commercial and operational experience to execute the Company's strategy of delivering commercialisation deals for its IP portfolio. Dr Bryan Dobson, Chairman of the Revolymer Remuneration Committee, is leading the search for the Company.

In the meantime, Revolymer CFO and Company Secretary Rob Cridland will become acting CEO, working closely with Dr David Pears, Chief Technology Officer, and Dr Jonathan Swanston, who heads the commercialisation of the Company's nicotine gum globally.

Ends

For further information please contact:

Revolymer plc

+44 (0) 1244 283 500

Rob Cridland

Panmure Gordon (UK) Limited

+44 (0) 20 7886 2500

Callum Stewart / Adam James (Corporate Finance)

Adam Pollock / Charles Leigh-Pemberton (Corporate Broking)

Citigate Dewe Rogerson

+44 (0)20 7638 9571

David Dible / Ginny Pulbrook / Malcolm Robertson

 

About Revolymer

Revolymer is a technology company that designs, develops and formulates novel polymers to improve the performance of existing consumer products within the FMCG and other industrial markets. Revolymer's strategy is to generate significant and growing revenue streams by licensing its unique and proprietary technologies to manufacturers and marketers within these global high value markets. Current applications for the Group's technologies are in the household products, personal care and coatings & adhesives markets (together "Consumer Specialties") and the medicated chewing gum and confectionery chewing gum (together "Gum") markets.

www.revolymer.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUNUORSSAAUAR
Date   Source Headline
1st Apr 20167:00 amRNSTotal Voting Rights
21st Mar 20167:00 amRNSFinal Results
16th Mar 20167:00 amRNSDirectorate Change
1st Mar 20168:41 amRNSTotal Voting Rights
25th Jan 20167:00 amRNSRenewed & Expanded Contract
11th Jan 20167:00 amRNSBlocklisting Interim Review
30th Nov 20155:21 pmRNSHolding(s) in Company
30th Nov 20157:00 amRNSTotal Voting Rights
30th Oct 201512:30 pmRNSTotal Voting Rights
21st Sep 20157:00 amRNSInterim Results
18th Sep 20157:00 amRNSDirectorate Change
7th Sep 201512:18 pmRNSTotal Voting Rights
2nd Sep 20157:00 amRNSBlocklisting Interim Review
1st Sep 20157:03 amRNSLicence with OCI Alabama LLC
15th Jun 201512:27 pmRNSHolding(s) in Company
3rd Jun 20157:00 amRNSGlobal licence signed with Solvay
20th May 201512:17 pmRNSResult of AGM
15th May 20151:21 pmRNSHolding(s) in Company
15th May 20151:17 pmRNSHolding(s) in Company
11th May 20157:05 amRNSDirector Declaration
5th May 20157:01 amRNSDirector/PDMR Shareholding
13th Apr 20157:00 amRNSNotice of AGM
30th Mar 20157:00 amRNSPreliminary Results
24th Mar 20157:15 amRNSDirector Declaration
9th Jan 20157:00 amRNSBlocklisting Interim Review
5th Jan 201512:00 pmRNSTotal Voting Rights
11th Dec 20147:00 amRNSHolding(s) in Company
10th Nov 20147:00 amRNSPatent Infringement Settled and Discontinued
10th Oct 20144:22 pmRNSTotal Voting Rights
29th Sep 20147:00 amRNSInterim Results
25th Sep 20147:00 amRNSGlobal licence signed with Solvay
26th Aug 20147:00 amRNSNew CEO start date confirmed
9th Jul 20147:00 amRNSBlocklisting Interim Review
4th Jul 20147:00 amRNSAppointment of Chief Executive Officer
2nd Jul 20147:00 amRNSTotal Voting Rights
23rd Jun 20147:01 amRNSNotification of Major Interest in Shares
23rd Jun 20147:00 amRNSNotification of Major Interest in Shares
9th Jun 20147:00 amRNSUS supply agreement for nicotine chewing gum
3rd Jun 20147:00 amRNSTotal Voting Rights
22nd May 201412:34 pmRNSResult of AGM
30th Apr 20143:16 pmRNSNotification of Major Interest in Shares
24th Apr 20147:00 amRNSAward under Long Term Incentive Plan
23rd Apr 201412:45 pmRNSNotification of Major Interest in Shares
23rd Apr 20147:00 amRNSNotice of AGM
22nd Apr 201411:58 amRNSTotal Voting Rights
14th Apr 20147:00 amRNSAward of Technology Strategy Board funding
31st Mar 20147:00 amRNSPreliminary Results
3rd Mar 20147:00 amRNSTotal Voting Rights
30th Jan 201411:39 amRNSBlock Listing
27th Jan 20147:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.